A Compound Inhibits Biofilm Formation of Staphylococcus aureus from Streptomyces

Biol Pharm Bull. 2015;38(6):889-92. doi: 10.1248/bpb.b15-00053.

Abstract

Biofilm is one virulence factor of bacteria. It contributes not only to bacterial adherence to many kinds of infection-establishing surfaces, but also to bacterial resistance against antimicrobial agents and antiseptic agents. Thus, inhibitors of bacterial biofilm formation should be useful in the prevention of infections. We found that a culture of Streptomyces sp. strain MC11024 showed inhibitory activity on biofilm formation by Staphylococcus aureus and isolated streptorubin B as an inhibitor of this formation in S. aureus. The biofilm formation of methicillin resistant S. aureus (MRSA) N315 was reduced to less than 30% at 1 µg/mL of streptorubin B, and at this concentration cell growth was not affected. Our study suggests that streptorubin B has the potential to be a leading compound of anti-infectious agents of S. aureus.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Biofilms / drug effects*
  • Methicillin Resistance
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity
  • Microbial Interactions
  • Microbial Sensitivity Tests
  • Prodigiosin / analogs & derivatives*
  • Prodigiosin / metabolism
  • Prodigiosin / pharmacology
  • Staphylococcal Infections / microbiology*
  • Streptomyces / metabolism*

Substances

  • Anti-Bacterial Agents
  • streptorubin B
  • Prodigiosin